Clinical Trials Directory

Trials / Completed

CompletedNCT03306914

Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

Plasma Volume Expansion for Optimum Renal Transplant Surgery: Albumin Versus Starch

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.

Conditions

Interventions

TypeNameDescription
OTHERAlbumin resuscitationAlbumin 5% is used as the intra-operative colloid
OTHERHydroxyethylstarch resuscitationHydroxyethyl starch 6% is used as the intra-operative colloid
DRUGAlbumin 5%Infusion of Albumin 5% intra-operatively
DRUGHydroxyethylstarch 6%Infusion of Hydroxyethylstarch 6% intra-operatively

Timeline

Start date
2017-10-15
Primary completion
2019-02-01
Completion
2019-02-01
First posted
2017-10-11
Last updated
2020-01-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03306914. Inclusion in this directory is not an endorsement.